News & Views: Articles
To support Jeans for Genes Day 2019, here we focus on Huntington’s disease to raise awareness for the children and their families affected by this genetic disorder.
At Porterhouse, we are proud and passionate about the work we do with our partners to improve people’s lives. In this instance, our article looks at lymphoma and the latest advances in the personalised treatment of the disease.
Porterhouse Medical looks at some of the opportunities and challenges presented by the rare disease market, and how successfully navigating the space requires a different approach to medical communications.
The theme for #WorldMSDay 2019 is #MyInvisibleMS, which aims to raise awareness that although people with multiple sclerosis (MS) might look well, they may be experiencing unseen, debilitating symptoms. Our article to explores this issue further …
Fabrice Allum, MD of Porterhouse Insights, looks at behaviour change, and the value of measuring the real-world impact of medical communication and education programmes on behaviour.
Ovarian cancer is the second most lethal gynaecological cancer worldwide. To raise awareness of this often fatal disease, our article looks at its symptoms, current treatments and future therapies:
To support World Hemophilia Day 2019, our infographic highlights three important facts about bleeding disorders to help raise awareness of the urgent need for ‘treatment for all’. Please take a look …
It is well known that the United Nations has core goals to tackle matters such as eliminating poverty, improving gender equality and combatting climate change 1, but did you know that happiness also features on the agenda? 2 In 2011, all 193 member states of the United Nations agreed to officially recognise happiness as a …
To help raise awareness for Rare Disease Day, our intern interviewed Debbie, the office manager at Porterhouse Medical, on what it’s like to live with a rare disease.
The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. Here we focus on two areas of personalised medicine from the oncology setting.